(±) -Iroxanadine
(±) -Iroxanadine (BRX 005; BRX 235), a vasculoprotector, is a p38 kinase and HSP protein activator. (±) -Iroxanadine has the potential for atherosclerosis and vascular diseases research[1].
Product Specifications
CAS Number
203805-20-3
Product Name Alternative
BRX 005; BRX 235
UNSPSC
12352005
Target
HSP; p38 MAPK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; MAPK/ERK Pathway; Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/racemic-iroxanadine.html
Solubility
10 mM in DMSO
Smiles
C1(C2=CC=CN=C2)=NOCC(CN3CCCCC3)N1
Molecular Formula
C14H20N4O
Molecular Weight
260.33
References & Citations
[1]A E Kabakov, et al. Pharmacological attenuation of apoptosis in reoxygenated endothelial cells. Cell Mol Life Sci. 2004 Dec;61 (24) :3076-86.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC433157 20 µg
DNA Polymerase lambda (POLL) (NM_001174085) Human Over-expression Lysate
Sign In for Pricing
View Details 
LC426898 20 µg
CD71 (TFRC) (NM_001128148) Human Over-expression Lysate
Sign In for Pricing
View Details 
